logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2020-06-04 LIGAND PHARMACEUTICALS INC Berkman Charles S
(SVP, Gen. Counsel & Secretary)
S Common Stock D 11146 $118.59 - $118.59 $1,321,775
2019-02-15 LIGAND PHARMACEUTICALS INC Korenberg Matthew E
(EVP,Finance & Strategy and CFO)
F Common Stock D 1166 $120.86 - $120.86 $140,922
2019-02-15 LIGAND PHARMACEUTICALS INC FOEHR MATTHEW W
(President and COO)
F Common Stock D 2826 $120.86 - $120.86 $341,549
2019-02-15 LIGAND PHARMACEUTICALS INC HIGGINS JOHN L
(Chief Executive Officer)
F Common Stock D 4917 $120.86 - $120.86 $594,267
2020-03-13 LIGAND PHARMACEUTICALS INC FOEHR MATTHEW W
(President and COO)
M Common Stock A 2000 $21.92 - $21.92 $43,840
logo   

Please login to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.4